Abstract: Functionalized indoles are recurrent motifs in bioactive natural products and pharmaceuticals.W hile transition metal-catalyzed carbene transfer has provided an attractive route to affordC 3-functionalized indoles,t hese protocols are viable only in the presence of N-protected indoles,o wingt oc ompetition from the more facile NÀH insertion reaction. Herein, ab iocatalytic strategy for enabling the direct C À Hf unctionalization of unprotected indoles is reported. Engineered variants of myoglobin provide efficient biocatalysts for this reaction, which has no precedents in the biological world, enabling the transformation of abroad range of indoles in the presence of ethyl a-diazoacetate to give the corresponding C3-functionalized derivatives in high conversion yields and excellent chemoselectivity.T his strategy could be exploited to develop ac oncise chemoenzymatic route to affordthe nonsteroidal anti-inflammatory drug indomethacin.
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Functionalized indoles are structural motifs found in many biologically active molecules,i ncluding alkaloids,a grochemicals,a nd drugs. [1] Because of their relevance as privileged scaffolds in medicinal chemistry,methods for the synthesis of functionalized indoles have received significant attention. [2] Among them, indole functionalization via transition-metalcatalyzed carbene transfer provides an attractive route to C3-substituted indoles,w hich constitute the core structure of various drugs [3] and medicinally important agents. [4] Kerr, Davis,F ox, and Hashimoto reported the successful application of Rh-based catalysts for realizing this transformation with diazo compounds. [5] More recently,o ther catalytic systems have been introduced to enable these reactions. [6] Invariably,h owever,t he scope of these protocols have been limited to the CÀHf unctionalization of indoles in which the NÀHg roup is masked either through alkylation or via aprotecting group, [5, 6] due to the inherently higher reactivity of this functional group toward carbene insertion. The application of these catalysts to unprotected indoles have indeed resulted in mixtures of NÀH, CÀH, and double NÀH/ CÀHi nsertion products. [5a, 6b,7] These limitations impose the need of additional protection/deprotection steps for the functionalization of indoles using carbene transfer chemistry (Scheme 1).
In previous work, we established that engineered variants of myoglobin, asmall (15 kDa) heme-containing protein, can provide efficient catalysts for carbene transfer reactions involving a-diazoesters,i ncluding olefin cyclopropanations [8] and carbene YÀHi nsertion (Y = N, S) [9] reactions,a mong others. [10] Biocatalytic carbene transfer reactions using other hemoproteins or metalloprotein scaffolds have also been reported. [11] More recently,w ee stablished that myoglobin variants incorporating non-native first-row transition metals (for example,Co, Mn) are also viable catalysts for promoting carbene C(sp 3 )-H insertion, [12] ar eaction previously achievable only using precious metals (for example,I r).
[11e] These findings prompted us to investigate the reactivity of myoglobin in the context of the C(sp 2 )ÀHf unctionalization of indoles.H erein, we report the successful implementation of ab iocatalytic strategy for the chemoselective functionalization of the C3 C À Hbond in unprotected indoles (Scheme 1).
We began these studies by testing the activity of wild-type sperm whale myoglobin (Mb) and its distal histidine variant Mb(H64V) [8a, 9a] toward the conversion of indole (1)tothe C3-functionalized product (3)i nt he presence of ethyl adiazoacetate (2)a st he carbene donor (Table 1) . However, neither reactions led to appreciable formation of the desired product 3,aresult comparable to that obtained using other hemoproteins or simple hemin as the catalyst (0-1 %c onversion;S upporting Information, Table S1 ). Since mutation of the amino acid residues within the distal pocket of Mb was previously found to greatly affect its carbene transfer reactivity, [8a, 9] we then extended these studies to ap anel of Mb variants,i nw hich each of the active site residues Leu29, Phe43, Va l68, and Ile107 is substituted by an amino acid bearing as ide chain group of significantly different size (for example,Leu29!Ala or Phe;Phe43!Ile or Ser). While the majority of these Mb variants showed no or only modest improvement in product conversion (0-5 %; Supporting Information, Table S1 ), Mb(H64V,V64A) was found to constitute asignificantly more efficient catalyst for this reaction, producing 3 in 50 %c onversion (Table 1) . Importantly,t he Mb(H64V,V68A)-catalyzed reaction proceeds with excellent chemoselectivity,y ielding 3 as the only observable product. This result is in stark contrast with that obtained from reactions with Rh 2 (OAc) 4 as the catalyst, from which nearly equal amounts of 3 (45 %) and NÀHi nsertion by-product (42 %) were formed, along with some double insertion product (13 %; Table 1 ; Supporting Information, Figure S1 ). Encouraged by these results,the Mb(H64V,V68A)-catalyzed transformation was targeted for optimization. Thee fficiency of this reaction was found to have aslight dependence on pH (Supporting Information, Table S2), with ap Ho f9being optimal (Table 1) . However,amore substantial improvement in product yield (54 %!85 %) was achieved by increasing the indole/EDAratio from 1:1to1:2 (Table 1) . Despite the excess diazo reagent and the single-addition protocol, no carbene dimerization (to give diethyl maleate/fumarate) or reaction with water (to give ethyl glycolate) was observed, highlighting the high chemoselectivity of the biocatalyst also with respect to these potential side reactions.
Under catalyst-limited conditions (0.2 mol %), Mb(H64V,V68A) catalyzes about 168 turnovers (TON). These TONv alues are lower than those supported by this variant in other carbene transfer reactions with EDA( 1000-10 000), [8a,9,10] but they compare favorably (3-to 6-fold higher) with those reported using Pd-or Cu-based catalysts for the C3 functionalization of N-protected indoles. [6c,d] From timecourse experiments,t he Mb(H64V,V68A)-catalyzed conversion of indole to 3 was determined to proceed with an initial rate of about 10 turnovers min À1 and that to reach completion in less than 15 minutes (Supporting Information, Figure S2 ). Control reactions confirmed that the ferrous form of Mb(H64V,V68A) is responsible for catalysis.
Given the feasibility of performing Mb-catalyzed carbene transfer reactions directly in whole cells, [8b, 13] we next investigated the viability of this approach for the biocatalytic C À H functionalization of indole.Accordingly,whole-cell biotransformations were carried out using Mb(H64V,V68A)-expressing E. coli cells (C41(DE3)) [14] in the presence of the optimized indole:EDAratio of 1:2. Interestingly,aprogressive improvement in product yields was observed upon decreasing the cell density in these reactions (Supporting Information, Table S2 ), ap henomenon we tentatively attributed to the sequestration or utilization of the indole substrate by the cells. Importantly,u nder optimal conditions (OD 600 = 20), quantitative conversion of the indole substrate to the desired CÀH functionalization product 3 was achieved (Table 1) . TheTON values measured in this reaction was comparable to that obtained with purified protein (82 vs.106), indicating anearly optimal utilization of the intracellularly expressed biocatalyst.
Using the whole cell protocol, the scope of the reaction was then probed using ap anel of indole derivatives.A s summarized in Scheme 2, avariety of 5-(4a-7a), 6-(8a), and 7-substituted indoles (9a)c ould be efficiently processed by the Mb variant to give the corresponding C3-functionalized products 4b-9b in quantitative conversions (> 99 %). 9b was isolated in 61 %y ield. As an exception, 5-methoxy-indole (7a)was converted to 7b with only moderate efficiencyusing the standard protocol (28 %). Significantly improved conversion of this substrate was obtained however using purified Mb(H64V,V68A) and sequential catalyst additions (77 %). Fore ach of the indole substrates,t he desired carbene CÀH insertion product was the only detectable product, indicating that the metalloprotein catalyst maintains excellent chemoselectivity toward CÀHfunctionalization over the more facile carbene N-H insertion reaction regardless of the position and electronic effect of the substituent on the indole ring.
Next, we examined the ability of Mb(H64V,V68A) to accept C2-substitued (10 a), N-methylated (11 a), and doubly substituted indole derivatives such as 12 a, 13 a,a nd 14 a (Scheme 2). Although the corresponding CÀHf unctionalization product (10 b-14 b)was obtained in each case,the yields were generally modest (5-26 %), denoting ascope limitation of this Mb variant across this subset of indole derivatives.T o identify ab etter catalyst for these substrates,t he original panel of Mb variants was screened against 14 a,w hich bears substitutions at both the C2 and C5 positions and was recognized as ap otential precursor for ad rug molecule (see below). Interestingly,m any of these Mb variants displayed significantly higher activity (2-to 5-fold) on this substrate compared to Mb(H64V,V68A) (Supporting Information, Table S3 ) despite their inferior performance in the context of indole (Supporting Information, Table S1), thus denoting ac lear preference of these biocatalysts for bulkier indole substrates.A mong them, Mb(F43S,H64V) and Mb(L29F,H64V) emerged as the most promising catalysts for this reaction, furnishing 14 b in 31 %a nd 41 %y ield, respectively (Supporting Information, Table S3 ). Thel atter reaction could be further optimized to give 14 b in 80 % (Scheme 2). Gratifyingly,a long with 14 a,M b(L29F,H64V) was found to exhibit improved activity also toward 2-methyl-, 5-methyl-N-methyl-, and 5-chloro-N-methyl-indole,y ielding the corresponding products 10 b, 12 b,and 13 b,respectively,in 50-85 %conversion (Scheme 2). For 12 b,this corresponds to an early 8-fold higher catalytic efficiency compared to Mb(H64V,V68A) (85 %v s. 10 %). While being complementary in terms of substrate scope,Mb(L29F,H64V) shares with Mb(H64V,V68A) excellent chemoselectivity for the CÀH functionalization reaction (no detectable N-H insertion product) and comparable kinetics (initial rate:7 -10 TON min À1 ). Mb-catalyzed carbene transfer reactions are believed to proceed via the formation of an electrophilic heme-bound carbene intermediate, [8a, 15] which can react with various nucleophiles such as olefins, [8a] amine, [9a] thiols, [9b] or phosphines. [10] Based on the ability of this reactive intermediate to give rise to sulfonium ylides upon reaction with thiol/ thioether nucleophiles [9b,16] and the well-established nucleophilicity of indoles at the C3 site, [17] aplausible mechanism for the Mb-catalyzed indole CÀHfunctionalization is proposed in Scheme 3. According to it, reaction of the catalytically active ferrous Mb (I)w ith the diazo reagent leads to the hemecarbene intermediate II,which undergoes nucleophilic attack by the indole substrate to yield the zwitterionic species III. From this intermediate,the final product can then arise from a[ 1,2]-proton shift from the C3 atom to the ester a-carbon atom or, alternatively,through dissociation of the zwitterionic enolate followed by protonation by the solvent. To discriminate between these pathways,t he enzymatic reaction was performed with 1-methyl-3-deutero-indole (11 a-3-d) . Insightfully,the product of this reaction showed complete loss of the deuterium label (Supporting Information, Figure S4 ), thus supporting the involvement of solvent-mediated protonation. This result, along with the absence of akinetic isotope effect (KIE) in reactions with 11 a-3-d vs. 11 a (Supporting Information, Figure S4 , S5), also rule out ac arbene CÀHi nsertion process,asinthe latter case retention of the deuterium label in the product and ap ositive KIE [18] would be expected. On the other hand, no observable formation of aC 2/C3 cyclopropane intermediate disfavors,w ithout necessarily excluding, an alternative scenario involving ac yclopropanation/ fragmentation pathway.
[6b] Overall, the proposed mechanism shares similarities with those proposed for related reactions promoted by Rh- [5c] and (non-heme) Fe-based catalysts [6a] but differs from that reported for indole functionalization with diazo reagents with Cu complexes.
[6b]
By comparison with Mb and Mb(H64V) ( Table 1) , the enhanced reactivity of Mb(H64V,V68A) toward in this reaction can be largely attributed to the V68A mutation. This amino acid substitution expands the active site in proximity of heme cofactor, which could facilitate attack of the heme-bound carbene by the indole (II!III), as previously observed for other nucleophiles. [9] At the same time,t he diminished reactivity of Mb(H64V,V68A) toward C2-substituted indoles (that is, 10 b and 14 a;S cheme 2) can be rationalized based on increased steric interactions between the C2 substituent and the porphyrin ring in the hemoprotein (Scheme 3). Interestingly,t his substrate scope limitation was effectively overcome using Mb (L29F,H64V) . From the structure-activity data gathered for closely related Mb variants (for example,M b(H64V) and Mb(L29A,H64V);S upporting Information, Table S3 ), the superior reactivity of Mb(L29F,H64V) toward C2-substituted or other bulky indole substrates appears to depend upon the presence of aP he residue at position 29. Am olecular model of Mb(L29F,H64V) shows that Phe29 projects its side-chain phenyl group above the heme cofactor (Supporting Information, Figure S3 ). This arrangement is well suited to potentially favor the interaction (for example,v ia p stacking) and/or affect the orientation of the indole substrate during attack to the heme-carbene intermediate (II!III,Scheme 3), possibly reducing steric clashes between the C2 substituent and heme ring. Similar protein/substrate interactions could also help dictate the high chemoselectivity of the biocatalyst toward C3 functionalization over NÀHc arbene insertion, although further studies are clearly warranted to elucidate these aspects in more detail.
To further assess the synthetic value of the present method, the synthesis of the non-steroidal anti-inflammatory drug indomethacin (16)w as targeted via ac hemoenzymatic route integrating Mb-catalyzed indole CÀHfunctionalization (Scheme 4). Starting from commercially available 2-methyl-5-methoxyindole (14 a), ap reparative-scale (1 mmol) reaction with Mb(L29F,H64V)-expressing cells afforded about 0.1 gof the desired C3-functionalized product 14 b in 40 %i solated yield. N-acylation of this intermediate with p-chlorobenzoyl chloride,followed by hydrolysis afforded the target drug. This chemoenzymatic sequence furnishes am ore concise route than that originally reported for the synthesis of this molecule (3 vs.5steps) [3b] and av iable alternative to more recent syntheses involving precious metal catalysts. [19] More importantly,t hese results provide ap roof-of-principle demonstration of the scalability of the Mb-catalyzed transformation disclosed herein.
In summary,w eh ave reported the first example of abiocatalytic strategy for carbene-mediated functionalization of indoles.T his approach could be applied to the C3 functionalization of unprotected indoles,agoal previously unattainable using synthetic transition metal catalysts owing to competition from the inherently more favorable carbene N À Hi nsertion reaction. Using two engineered Mb variants with complementary substrate profile,abroad range of variously substituted indole derivatives,i ncluding C2-substituted and doubly substituted indoles,could be processed with high efficiencya nd excellent chemoselectivity.T his newly developed Mb-catalyzed transformation could be further leveraged to implement ac oncise chemoenzymatic route for the synthesis of adrug molecule.This study expands the range of abiotic transformations accessible through engineered and artificial metalloenzymes. [20] 
